Pathway overview
Kidney transplantation is a treatment option for some people with kidney failure. It may offer greater freedom from dialysis, but it requires major surgery, lifelong follow-up and medicines that suppress the immune system. A transplant team must assess whether the likely benefits outweigh the individual risks.
A living-donor pathway and a deceased-donor pathway are not interchangeable. Living donation requires a willing donor, independent donor assessment and lawful approval. Deceased-donor access is controlled by national allocation rules; international patients should never assume that travelling creates waiting-list access.
International planning should start with a licensed kidney transplant programme that can confirm whether it evaluates non-residents, which donor pathways are legally available and which records are needed. MedTransplant does not find donors or influence allocation.
Important distinctions
- Living-donor transplant
- A potential donor is evaluated separately for medical suitability, informed and voluntary consent, psychosocial wellbeing and legal compliance. Donor safety must remain independent of the recipient’s need.
- Deceased-donor transplant
- A donated kidney is allocated through a regulated national system. Eligibility, priority and access can depend on clinical criteria, residence, citizenship and local law.
- Candidate evaluation
- The hospital assesses whether transplantation is medically appropriate and whether identified risks can be managed. No website or coordinator can make that decision.
- Long-term care
- Transplantation requires anti-rejection treatment, monitoring for infection and other complications, and reliable follow-up with the transplant team.
How the evaluation pathway usually develops
- 01
Prepare the clinical record
Gather the kidney diagnosis, dialysis history, current medicines, previous operations, infection and cancer screening, and recent heart and laboratory investigations requested by the hospital.
- 02
Confirm the lawful donor route
Ask the hospital which living-donor relationships and documents are accepted, or whether any regulated deceased-donor pathway is available to a non-resident.
- 03
Complete multidisciplinary evaluation
Recipient—and, when relevant, donor—assessment may involve nephrology, transplant surgery, anaesthesia, infectious-disease, psychosocial and other specialist review.
- 04
Plan for surgery and lifelong follow-up
Before travel, understand admission timing, expected monitoring, immunosuppressive medicines, complication planning and how follow-up will continue after returning home.
Topics a hospital may evaluate
Requirements differ by person, programme, and jurisdiction. A licensed transplant team may consider:
- Kidney diagnosis, current kidney function and dialysis history
- Cardiovascular, surgical and anaesthetic risk
- Active infection, vaccination status and cancer screening
- Medication adherence, psychosocial support and ability to attend long-term follow-up
- Blood group, tissue compatibility and antibody testing
- Separate donor medical and psychosocial assessment where living donation is lawful
- A safe post-transplant medication and monitoring plan in the patient’s home country
Questions to ask a licensed transplant hospital
- Does this campus hold authorization for kidney transplantation, and does it evaluate international patients?
- Which living-donor relationships and legal documents are accepted?
- Can non-residents access deceased-donor allocation under current national rules?
- Which tests must be completed before the team will review the case?
- How are the donor and recipient evaluated independently?
- Who provides urgent advice and routine follow-up after the patient returns home?
